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1. Introduction 
Metabolomics is a discipline aiming to characterize a phenotype by means of metabolome 
analysis. In recent years, it has developed into an accepted and valuable tool in life sciences 
and its use has been growing rapidly in the study of microbial, plant, and mammalian 
metabolomes. It has been shown to be an effective tool in characterizing cancer cells and their 
response to anticancer drugs (Griffiths & Chung, 2008). To assess the effects of drugs on 
important pathways in clinical trials of innovative therapies, metabolomic approaches might 
be more cost-effective than those that measure specific molecular targets (Workman et al., 
2006). The derived biomarkers applied in early clinical trials are expected to help identify 
appropriate patients, provide proofs of concepts, aid decision making, and ultimately reduce 
the high level of attrition and costs of drug development (Sarker & Workman, 2007). 
The biological specimens used in human metabolomic studies are e.g. urine (Weiss et al., 
2007), blood plasma (Boernsen et al., 2005), and saliva (Walsh et al., 2006). All of them can 
play an important role in the diagnostic processes of problem illnesses. The individual 
metabolome of human biofluids is defined by genetic factors but it can also be affected by 
diet, age, disease, etc. In this respect, the use of human cell cultures offers a good alternative, 
since the influence of the above-mentioned factors is minimized in a culture where a defined 
extracellular environment takes place (Rabinowitz et al., 2006). 
As concerns the analytical techniques applied in metabololmics, chromatographic 
techniques coupled to mass spectrometry play an important role. For the analysis of organic 
acids, amino acids, and sugars gas chromatography-mass spectrometry (GC-MS) after 
derivatization is widely applied. Since biological materials represent a very complex matrix, 
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classical GC-MS techniques can struggle with the high number of components present and 
the occurring co-elutions. In this respect, comprehensive two-dimensional gas 
chromatography (GC × GC) brings significant benefits and its coupling with time-of-flight 
mass spectrometry (GC × GC-TOF-MS) has become an emerging technique in this field 
(Koek et al., 2011). 
Due to a polar nature of target compounds, derivatization procedure is required for GC-MS 
analysis. Although silylation is the most widely used approach, it has certain limitations 
such as formation of more products from a single analyte. Moreover, the ratios between 
individual silylated products can change with time. To overcome these drawbacks, other 
derivatization procedures such as indirect alkylation via chloroformates or acylation have 
been used (Husek & Simek, 2006). 
This contribution is focused on the application of comprehensive two-dimensional gas 
chromatography coupled to time-of-flight mass spectrometry for the analysis of human 
biological materials (urine, plasma, and cultured skin fibroblasts) in relation to diagnosing 
metabolic disorders, cell metabolism quenching, and drug metabolomic impact prediction. 
2. Comprehensive two-dimensional gas chromatography 
2.1 Basic theory 
Comprehensive two-dimensional gas chromatography (GC × GC) is a technique utilizing two 
columns of different selectivity connected in series by the modulation device. The modulator 
cuts slices from the first-dimension column effluent and re-injects them to the secondary 
column. Due to the difference in column polarity, each simple compound is subjected to two 
independent separation mechanisms. Compared to one-dimensional GC, this technique brings 
dramatically increased peak capacity, improved peak resolution, and up to an order of 
magnitude increase in compounds’ detectability. In contrary to heart-cutting variety, in GC × 
GC all effluent from the primary column passes through the secondary column, maximizing 
sample resolution throughout the entire analysis (Gorecki & Harynuk, 2004; Beans & 
Brinkman, 2005). A theoretical and practical comparison of one-dimensional GC and GC × GC 
in terms of peak capacity has been published by Blumberg et al., 2008. 
In GC × GC, two basic orthogonality rules should be kept: (i) independence of separation 
mechanisms, i.e. the two columns should possess of different selectivity; (ii) preserving of 
the first-dimension separation, i.e. the peaks already separated on the first column must not 
be mixed-up in the modulator. For this reason, the modulation must occur at frequency of at 
least 3-5 modulations per first dimension peak. But in practice, the full independence is not 
possible, so in the case of GC × GC this must be considered as the degree of GC × GC system 
orthogonality, or “relative” or “partial” orthogonality which can be characterized by the 
percent usage of the available separation space (Ryan et al., 2005; Zhu, 2009). 
2.2 Technical aspects 
GC × GC occurs by the subsequent re-injection of effluent from one chromatographic 
column into the second “orthogonal” column. As already mentioned, a minimum number of 
modulations per first dimension peak are required to maintain the first dimension 
separation which typically results in modulation periods of 1-5 s. A flash separation on the 
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second dimension column has to be completed before the next modulation cycle starts. In 
this way, the separation obtained in the first dimension is preserved and additional 
separation on the second column is obtained. The re-injection process is called modulation 
and is enabled by an interface device called modulator, often referred to as the “heart” of the 
system. A GC × GC modulating interface can be placed at the end of the first dimension (1D) 
or at the beginning of the second dimension (2D), e.g. for thermal modulators, or between 
the columns (valve-based modulators). Nowadays, cryo-modulators which trap primary 
column effluent below ambient temperatures with the use of various cooling mechanisms 
are most commonly used (Edwards et al., 2011). 
As a typical column set-up, a nonpolar column is used as the 1D and polar one in the 2D. 
Under these conditions, separation according to the volatility of the compounds occurs in the 
1D column while “polarity” separation dominates in the 2D column. In principle, the column 
arrangement can be inverted. Both set-ups have their advantages and disadvantages and 
therefore the right set-up must be a result of optimization of a particular application. As 
concerns the column dimension, the first column is relatively long (typically 30-60 m) and 
normal bore (typically 0.25 mm with 0.25 µm film thickness). The second column has to be 
very short and narrow (typically 1-2 m of a 0.1 mm column with 0.1 µm film thickness) to 
perform a very fast separation. The use of such narrow-bore column results in limited sample 
capacity and easy 2D column overloading, especially for biological samples. This limitation has 
been overcome by the use of wider-bore columns in the second dimension (Koek et al., 2008).  
Primary GC × GC data are a series of second dimension chromatograms registered by the 
detector. Appropriate software reconstructs the second dimension chromatograms into 
three-dimensional plots or contour plots as shown in Figure 1.  
 
Fig. 1. Construction of a contour plot. The 1D effluent containing not fully separated analytes 
is modulated to create a series of short 2D chromatograms. They are reconstructed by the 
software form a three-dimensional view. For the practical purposes the contour plot view is 
more feasible. 
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As concerns the detectors applicable in GC × GC, the peak width generated by this 
technique must be taken into account. Typical GC × GC peaks are 0.1-0.3 s wide, thus to get 
a sufficient number of data points to accurately describe the shape of the peak (at least 10 
points per peak) a detector must collect data at a rate of at least 100 Hz. For the coupling of 
GC × GC with MS detection, a high-speed TOF-MS is the technique of choice in most 
studies. Quadrupole MS have been also applied in GC × GC (Adahchour et al., 2006) with 
some compromises in the data density and mass range. 
Since GC × GC generates large quantities of data, appropriate software tools become very 
important, not only for data acquisition but also visualization and interpretation. Depending 
on the data itself, various operations may be required, typically including background 
removal, mass spectral deconvolution, peak finding, combination of modulated peaks, peak 
height (area, or other characteristics) computation, identification of the found peaks by the 
comparison with mass spectral databases (or custom libraries), and finally export of analysis 
report (Reichenbach et al., 2004). 
2.3 Application of GC × GC and its current trends 
Since its introduction in 1991 (Liu & Philips, 1991), the GC × GC technique has gone through 
the years of rapid development. Today, GC × GC is widely used in many diverse areas which 
cover an interesting variety of applications. In general, the usage possibilities of GC × GC can 
be divided into three areas – fingerprints of very complex matrices, target analyses, and 
identification of unknown compounds. An excellent review on the GC × GC applications 
written by Adahchour et al. maps the usage of the technique from its introduction till 2008 in 
following fields – petrochemical products, environmental studies (soils and sediments, airs 
and aerosols, cigarette smoke), organohalogen compounds, food analysis (fats and oils, 
essential oils, alcoholic beverages), and also biological samples (Adahchour et al., 2008). 
A significant progress can be noted in biosciences applications. In the field of human 
metabolomics, it covers e.g. metabolomic profiling of infant urine (Kouremenos et al., 2010; 
Wojtowicz et al., 2010), biomarker discovery of diabetes mellitus (Li et al, 2009), defining the 
“metabolome” of psychical disorders like schizophrenia (Oresic et al., 2011), sterol analysis 
(Mitrevski et al., 2008), analyses of tumorogenic cells (Paskanti et al., 2010), identification of 
anabolic agents in doping control (Mitrevski et al., 2010), or enatioselective analyses 
(Wadhier et al., 2011). 
As regards the recent developments in GC × GC, the utilization of new stationary phases 
such as ionic liquids (Zapadlo et al., 2011), development of new modulators, e.g. (Panic et 
al., 2011), and improvement of data handling and evaluation (Wang et al., 2010; Kim et al., 
2011; Koek et al., 2011) should be mentioned. 
3. Derivatization via chloroformates 
Analytes derivatization is employed in many analytical methods that utilize GC as a final step. 
The dominant reasons for derivatization in GC are either to increase analytes volatility, to 
improve their chromatographic behaviour by decreasing of polarity or to increase the detector 
sensitivity of the target analytes. The group of silylation procedures is by far the dominant 
derivatization methods. Silylation is almost universal technique and the silyl groups increase 
the total ion current which leads to increase the sensitivity using positive ion MS (Wells, 1999).  
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On the other hand, this derivatization procedure has several disadvantages. First, it is time-
consuming and requires elevated temperature. Further, the silylation reactions result in the 
formation of many artifacts as well as forming of multiple peaks for the same compound or 
the presence of unexpected peaks in the chromatogram. Also, in the electron impact mass 
spectra of silylated compounds, the non-specific masses belonging to the silyl group prevail, 
while the molecular and other characteristic ions have low intensity, which complicates 
spectra interpretation. Finally, it is also important to mention the instability of the silylated 
compounds and its sensitivity even to the traces of moisture which makes sample 
preparation and storage more demanding (Little, 1999; Ong et al., 2010). 
As a promising alternative derivatization technique, an indirect alkylation via 
chloroformates appears. The sample preparation procedure is as follows. A portion of 
pyridine (serving as a catalyst) and an alcohol (to form esters) is added to the sample that is 
present in basic-aqueous environment. The reaction itself starts with the addition of an 
appropriate alkyl chloroformate. The reaction is fast (seconds) and no heating is needed. An 
illustration of derivatization reaction is shown in Figure 2. After the reaction, the derivates 
are directly extracted into the water-immiscible organic solvent (chloroform, isooctane) that 
can be immediately (or after drying by e.g. anhydrous sodium sulfate) injected. In this way a 
biological material (plasma, urine, cell extract) can be derivatized without any pretreatment.  
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Fig. 2. Derivatization method using methyl chloroformate (MCF). 2-Aminopropanoic acid 
(alanine) is converted to methyl 2-[(methoxycarbonyl)amino]propanoate 
Using this procedure, due to the reaction conditions (pH, presence of other solvents), many 
polar-functional groups are converted to the corresponding forms, i.e. – carboxy, amino, 
hydroxyl, and thiol groups to esters, carbamates, carbonates, and thiocarbonates, 
respectively. The reactions are robust with low-cost reagents and in majority cases (>95%) 
produce a single stable derivate that has an easily interpretable MS spectrum (Figure 3). 
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Fig. 3. MS spectrum of MCF derivate of valine 
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4. Material and methods 
4.1 Chemicals and reagents 
Internal standards (4-phenylbutyric acid for TMS, norvaline for MCF), ethoxyamine 
hydrochloride, methanol (HPLC grade), pyridine (p.a.), methyl-chloroformate (MCF, 99%, 
for GC), chloroform (≥99.9%, for HPLC), trypsin/EDTA (10×), N-methyl-N-
trimethylsilyltrifluoroacetamide (MSTFA), containing 1% of trimethylchlorosilane, 
Dulbecco’s Modified Eagle’s Medium, and amphotericin were purchased from Sigma–
Aldrich (St. Louis, USA). Fetal bovine serum was from PANBiotech (Aidenbach, Germany), 
sodium chloride solution (0.9%) from B Braun (Melsungen, Germany). Other chemicals for 
sample preparation, i.e. hydrochloric acid, sodium chloride, sodium hydroxide, anhydrous 
sodium sulfate, sodium bicarbonate, ethyl acetate (p.a.), and acetone (p.a.) were supplied by 
LACH-NER (Neratovice, Czech Republic). 5-Fluorouracil (250 mg in 5 mL) was from 
EBEWE Pharma (Unterach, Austria). Standard mixture of 32 amino acids and dipeptides 
(200 µmol/L) was from the EZfaast kit (Phenomenex, USA). All chemicals and reagents 
were of analytical grade or higher. 
4.2 Samples and their preparation 
4.2.1 Urine samples 
For the analysis of organic acids, urine samples were acidic-extracted into ethyl acetate, 
ethoxymated and silylated by MSTFA. We analyzed 10 healthy urines and urines from 
patients with inherited metabolic disorder. For more detail see (Wojtowicz et al., 2010). 
Analytes response was normalized to the concentration of creatinine measured by the 
common Jaffe rate method. 
4.2.2 Fibroblasts 
Human skin fibroblasts were cultured by standard protocol (Dulbecco’s Modified Eagle’s 
Medium, supplemented with 10% of fetal bovine serum and amphotericin 100 g/mL, 
37 °C, 5% CO2, 25 cm2 flasks) to confluence. The cells were harvested by quenching or 
trypsinization (see below). 
Quenchinq procedure: The cells were quenched by spraying-out of 20 mL of 60% aqueous 
methanol (v/v) pre-cooled to -50 °C using plastic syringe with bent needle. The flasks with 
quenched cells were kept on dry ice and the cells were extracted with 1 mL of cold (-50 °C) 
methanol solution (80%, v/v) while scraping. The cell debris in the methanol solution was 
drained out with pipette and another 1 mL of cold extraction solution to wash the flask was 
used. Both methanol fractions were combined, sonicated (1 min), and centrifuged (1800g, 
5 min) to remove the cell pellet and the supernatant was freeze-dried, silylated or alkylated 
via MCF. For the experiment with 5-fluorouracil (5-FU), the growing medium was 
supplemented with the drug (50 μmol/L) for 6, 24, and 48 hours before quenching 
procedure, respectively. 
Trypsinization: Before trypsinization the cells were washed twice with 0.9% sodium 
chloride solution and then the trypsin/EDTA solution was added. After 2 min, trypsin was 
deactivated by adding of 5 mL of a cultivation medium. The cell suspension was centrifuged 
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(260g, 5 min) and the pellet was extracted twice by 1 mL of 80% methanol. Combine extracts 
were freeze-dried. 
Freeze-dried intracellular metabolite extracts were derivatized for analysis by two-stage 
silylation procedure based on the method described previously (Koek et al., 2006). The dry 
extracts were derivatized with ethoxyamine hydrochloride (10 µL, 56 mg/mL in pyridine) 
and 20 µL of pyridine for 60 min at 40 °C. Subsequently, the extracts were silylated for 
50 min at 40 °C with 40 µL of MSTFA and 30 µL of pyridine. 
The MCF derivatization was as follows: Dry metabolite extract was dissolved in 100 µL of 
water and 200 µL of sodium hydroxide (0.5 mol/L). The mixture was transferred into the 
glass tube containing 20 µL of internal standard norvaline (0.1 mmol/L). After, 200 µL of 
methanol and 50 µL of pyridine as a catalyst were added and the mixture was briefly 
vortexed. The derivatization reaction was started by adding 20 µL of MCF and the mixture 
was then vortexed for 30 s. Another 20µL portion of MCF was added again followed by 
shaking for 30 s. To separate the MCF derivatives from the reactive mixture a 300 µL of 
chloroform was added and shaken 10 s followed by the addition of 300 µL of sodium 
bicarbonate solution (50 mmol/L) and shaking for an additional 10 s. For better layering, the 
tubes were centrifuged (1000g, 1 min). The upper aqueous layer was discarded and the 
chloroform phase was dried by adding a small portion of anhydrous sodium sulfate. The 
dry organic solution was transferred to a GC vial with an insert which was tightly capped 
and then analyzed. 
4.2.3 Plasma samples 
The control and patient plasma samples were from infants from routine diagnostic processes 
performed in the laboratory of authors. The diagnoses had been previously confirmed by 
biochemical, enzyme or molecular-genetic analyses in all the patients. We analyzed 10 
control samples and 19 samples with amino acids defects (phenylketonuria, PKU, maple 
syrup urine disease, MSUD, tyrosinemia I, TYR I, homocystinuria, HCYS, carbamoyl 
phosphate synthetase deficiency, CPS, ornithine transcarbamylase deficiency, OTC, and 
non-ketotic hyperglycinemia, NKH) (Janeckova et al., 2011). 
For the MCF derivatization procedure, 50 µL of plasma were pipetted into the glass tube 
containing 20 µL of internal standard norvaline (0.1 mmol/L). After addition of 200 µL of 
sodium hydroxide (0.5 mol/L), the derivatization procedure was the same as in the case of 
fibroblasts. 
4.3 Optimized analyses conditions  
A Pegasus 4D system consisting of an Agilent 7890A gas chromatograph (Agilent 
Technologies, Palo Alto, USA), a MPS2/CIS4/ALEX system (Gerstel, Mülheim an der Ruhr, 
Germany), and a Pegasus HT time-of-flight mass spectrometer (LECO Corporation, St. 
Joseph, USA) was used. The GC × GC system employed a dual-stage, quad-jet modulator 
and a secondary oven, both built-in to the Agilent GC oven. A consumable-free option of the 
modulator was employed. Compressed air was used for both hot and cold modulation jets. 
For the hot jets the air was resistively heated, while for the cold jets the air passed through a 
moisture filter and was cooled by immersion cooling (–80 °C). 
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The nonpolar/polar (BPX5, 30 m × 0.25 mm × 0.25 µm & BPX50, 2.0 m × 0.1 mm × 0.1 µm, 
both Supelco) column arrangement with a modulation on the first column was chosen. The 
columns were connected using a SilTite Mini Union (SGE, Ringwood, Australia). The oven 
temperature program differs due to the derivatization procedure – TMS: primary oven 
temperature: 40 °C (2 min), 8 °C /min to 155 °C (0.2 min), 10 °C/min to 255 °C (0.20 min), 
and isocratically 300 °C (5 min); secondary oven temperature: +5 °C above the primary oven 
temperature; modulator temperature: +50 °C above the primary oven temperature; 
modulation period: 3 s (hot pulse 0.6 s), solvent delay 650 s; MCF: 60 °C (1.5 min), 
15 °C/min, 300 °C (5 min), secondary oven temperature: +10 °C above the primary oven 
temperature; modulator temperature: +30 °C above the primary oven temperature; 
modulation period: 4 s (hot pulse 0.8 s), solvent delay 300 s. 
Other conditions were as follows:: carrier gas: helium at the corrected constant flow  
1 mL/min; splitless injection (1 min, 250 °C), 0.2–1 µL due to the application; TOF-MS: 
electron ionization (−70 eV); ion source temperature: 250 °C; acquired mass range: m/z 35-
550; acquisition rate: 100 spectra/s; detector voltage: −1500 V; transfer line temperature: 
250 °C.  
ChromaTOF software v. 4.24 (LECO Corporation, USA) was used for system control, data 
acquisition, and data processing. The NIST/EPA/NIH Mass Spectral Library (2008) was 
used for tentative identification of compounds, with confirmations by retention indices 
comparisons. System Gerstel was controlled by Maestro software v. 1.3 (Mülheim an der 
Ruhr, Germany). 
4.4 Data processing and quantification 
An automated data processing based on the so called “Reference” was performed by the 
ChromaTOF software. The analyte concentration was calculated from the deconvoluted 
total ion current (DTIC) peak area.  
Multivariate statistical data analyses (Principal Component Analysis – PCA, Hierarchical 
Cluster Analysis – CA) were performed using Statistica 8.0 (www.statsoft.com). A heat-map 
was created using the Cluster v. 3.0 software (http://bonsai.hgc.jp) and visualized by the 
TreeView v. 1.1.5 software (http://jtreeview.sourceforge.net).  
4.4.1 Deconvoluted total ion current 
Reference materials of rarely occurring pathological metabolites are not always easily 
available and/or their cost is considerably high. Therefore, it is a common practice to use the 
total ion chromatogram (TIC) signal for quantification along with the internal standard use. 
This approach was used also in this work. However, TIC quantification can overestimated 
results in case of chromatographic coelutions, which cannot be completely avoided even 
with GC × GC. 
This obstacle was overcome in our work by using deconvoluted total ion chromatogram 
(DTIC) for the quantification of the analytes. Deconvolution is a mathematical algorithm 
that is based on the absence of spectral skew and faster acquisition rates for peak apex 
definition in TOF-MS data. This algorithm mathematically separates mass spectra of 
compounds that chromatographically co-elute. In addition to producing deconvoluted 
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spectra, the ChromaTOF software also allows the calculation of DTIC peak area. 
Deconvoluted TIC is the portion of TIC area corresponding to a particular analyte in a co-
elution. An example is shown in Figure 4. 
 
 
 
Fig. 4. Creation of DTIC for suberylglycine 2TMS (analysis of urine extract). On the right the 
raw peak apex spectrum (up) and the spectrum after deconvolution (down) are shown. The 
similarity between the deconvoluted spectra and the spectra from the library was 895. 
4.4.2 Using the reference 
When a classical GC-MS is used, the chromatogram is typically reviewed manually by 
plotting characteristic masses in the segment of the expected retention time. To avoid such a 
time-consuming procedure, a ChromaTOF feature called “Reference” was applied. This 
procedure consisted of the following steps:  
i. The sample is processed using a general peak finding method (e.g. S/N 200). 
ii. Peaks of interest are exported to the Reference, which is a set of information containing 
the retention times and mass spectrum of each analyte, among other data. Criteria such 
as the retention time window-width in both dimensions and minimum spectral match 
are defined by the user.  
iii. The Reference is applied to target search for each analyte in the unknown sample and 
for the quantification of positively identified analytes. 
iv. If some new interesting analyte is found in newly processed sample, it can be added to 
the existing Reference. 
The retention time tolerances were determined based on the repeatability of retention times. 
The appropriate relative standard deviations (n=10) of the retention times of selected urine 
metabolites were under 0.17% and 1.74% for 1D and 2D, respectively (Wojtowicz et al., 2010). 
Using this approach, two References have been made – one for TMS and one for MCF-based 
derivatization which will be described in following sections. 
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5. Results and discussion 
5.1 Analysis of samples derivatized by silylation 
EZfaast standard solution (contains 32 amino acids and dipeptides), 10 healthy and 14 
pathological urine extracts, and 15 quenched fibroblast extracts derivatized by TMS were 
analyzed by a GC × GC-TOF-MS method and subjected to data processing procedure. After 
manual inspection of these peaks and confirmation of their identity by means of retention 
indices, a Reference was created from these compounds. This TMS compounds Reference 
contains 268 analytes at this moment. 
The analyzed compounds are organic acids (e.g. suberate, malonate, palmitate) and their 
derivates (e.g. 2-oxoisovalerate, lactate, vanillylmandelate, mevalonolactone), amino acids (e.g. 
glycine, valine, phenylalanine) and their derivates (e.g. 3,4-dihydroxyphenylalanine, cystine, 4-
hydroxyproline), N-acetylated amino acids (e.g. N-acetyl-tyrosine, N-acetyl-lysine), amines 
(e.g. ethanolamine, butanediamine), pyrimidines and purines (thymin, uracil, ureate), sugars 
(e.g. glucose), acylglycines (hippurate, propionylglycine, hexanoylglycine), and others (e.g. 
succinylacetone, indoleacetate, urea, cholesterol, furan-2,5-dicarboxylate).  
5.1.1 Analysis of urine acidic extract in relation to organic acidurias 
A large subgroup of Inherited Metabolic Disorders called organic acidurias is characteristic 
by increased levels of organic acids in urine or the presence of pathological ones not 
appearing in healthy urine. The diagnosis of organic acidurias is commonly performed by 
the analysis of urine after acidic extraction. Besides organic acids, some other types of 
metabolites also serving as pathological markers, are extracted. 
 
Fig. 5. GC × GC-TOF-MS contour plot from the analysis of healthy urine (A) and enlarged 
part (B) 
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Automated data processing with peak finding above S/N 200 was applied to the data, which 
resulted in the detection of 1353-3420 peaks in the set of studied urines. After sorting out GC 
column bleed peaks and the peaks belonging to the derivatization reagent, some 60% of the 
peaks remained. They are naturally occurring metabolites, pathological metabolites, nutrition 
artifacts, and drug artifacts, but most of the compounds are still not clearly identified. Our 
TMS Reference contains 153 identified and confirmed urine chemical species (from all 268 in 
the TMS Reference). In the Figure 5 is shown a 2D contour plot of healthy urine. 
To evaluate the newly developed GC × GC method as well as the data processing strategy 
described above, we selected external quality control samples (ERNDIM, 
http://www.erndim.unibas.ch/) and one sample from an asymptomatic patient with 
medium-chain acyl-CoA dehydrogenase deficiency, who had been diagnosed by neonatal 
screening sixth days after birth. Since the patient was in a non-crisis state, many biochemical 
markers of the disease were in normal levels, so he could be missed by GC-MS. Using GC × 
GC-TOF-MS with the TMS Reference we found both hexanoylglycine peaks, which, 
although present at low concentrations, are obviously pathological markers and confirm the 
presence of the disease. Figure 6 illustrates the major benefit of our approach – separation of 
main markers of the disease from an excess of naturally occurred metabolite. For more 
details see (Wojtowicz et al., 2010). 
 
Fig. 6. Enlarged part of a contour plot from the analysis of urine from a patient with 
medium-chain acyl-CoA dehydrogenase deficiency. Two peaks of hexanoylglycine 
derivatives (1 and 2TMS) are resolved from a large peak of 4-hydroxyphenylacetic acid 
2TMS. The deconvoluted spectrum (up) and the library hit belonging to the 2TMS derivate 
are shown (similarity 798) 
5.1.2 Analysis of cultured human skin fibroblasts – comparison of trypsin treatment 
vs. quenching  
The influence of most of external factors on the cell metabolomes is minimized in a culture 
where a defined extracellular environment takes place. To collect reliable metabolome data 
sets, culture and sampling conditions are crucial. The accurate analysis of intracellular 
metabolites requires a reliable sampling technique. Metabolites are generally labile species 
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and their reactions occur on a time scale much shorter than that of large molecule synthesis 
or degradation, with substantial changes in small molecule concentrations possible during a 
time scale of seconds (Canelas et al., 2008). 
The metabolomic analysis of adherent cell cultures presents a complex challenge, mostly given 
by limited sample sizes. The rapid quenching of the intracellular metabolism, simultaneously 
with the considerable removal of superabundant growing medium, are the main prerequisites. 
As a result of a known rapid turnover of intracellular metabolites, the sampling process should 
be very fast and cause minimal metabolome loss as a result of cell leakage. In this study, we 
compared trypsinization as the classical procedure for adherent cell harvesting (Dettmer et al., 
2011) with the simple quenching procedure developed in our laboratory. 
A set of studied fibroblasts has been analyzed by a GC × GC-TOF-MS method and the data 
was subjected to automated data processing with peak finding above S/N 200, which 
resulted in the detection of 431-601 peaks. Similarly as described in the section 5.1, our TMS 
Reference contains 72 identified and confirmed intracellular chemical species, from all 268 in 
the TMS Reference (Table 1). In the Figure 7 a 2D contour plot of analysis of the intracellular 
metabolites extracted from spray-quenched human cultured skin fibroblasts is shown. 
Acetate 
Aconitate 
Adipate 
Alanine 
2-Aminoadipate 
2-Aminobutyrate 
4-Aminobutyrate 
Aspargine 
Aspartate 
Azelaic acid 
β-Alanine 
Benzoate 
Capric acid 
Citraconate 
Citrate 
Cystathionine 
Cysteine 
Diphosphate 
2,3-Dihydroxybutyrate
3,4-Dihydroxybutyrate
Glucose 
Glutamine 
Glutarate 
Glycerol 
Glycerate 
Glycine 
Fumarate 
Hexenedioate 
Hippurate 
Histidine 
2-Hydroxyisobutyrate 
3-Hydroxyisobutyrate 
2-Hydroxybutyrate 
2-Hydroxyisobutyrate 
2-Hydroxyglutarate 
3-Hydroxyhippurate 
4-Hydroxyproline 
Cholesterol 
Isoleucine 
Itaconate 
Lactate  
Laurate 
Leucine 
Lysine 
Malate  
Maleate 
Mesaconate 
Methionine 
Myo-inositol 
Oleate 
Ornithine 
2-Oxoglutarate 
2-Oxo-3-methylvalerate
5-Oxoproline 
2-Oxovalerate 
Palmitate 
Panthotenate 
Phenylalanine 
Phosphate 
Picolinate 
Proline 
Pyruvate 
Serine 
Succinate 
Stearate 
Threonate 
Threonine 
Tryptophan 
Tyrosine 
Uracil 
Urea 
Valine 
Table 1. The list of 72 unique metabolites identified and confirmed in extracts of human 
cultured skin fibroblasts by GC × GC-TOF-MS 
In order to evaluate the effect of quenching vs. trypsinization, a cellular metabolome was 
determined in fibroblast cultures (n=6 for each method) from a single cell line. Data from 
analyses were corrected to percentages of a sum. The obtained compositional data were 
statistically analyzed. The geometric means for the single compounds were calculated. In 
order to be able to deal with Gaussian distribution of single compounds for variance 
analysis the data were transformed by the following equation [1/sqrt(2)*log(x/(1-x))], that 
represents a special case of so-called isometric log-ratio transformation (Egozcue et al., 
2003). The results from trypsin and quenching approaches were compared as the natural 
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logarithms of ratios of means and variations (Figure 8) and multivariate statistics – PCA and 
CA (Figure 9). It is clearly visible that the quenching technique substantially affects the 
concentrations of a number of metabolites. Several metabolites (e.g. citrate, lysine) differ by 
an order of magnitude. From the variations it is also evident that sample preparation by 
means of conventional trypsinization provides substantially more variable data in 
comparison to quenching by means of spraying. 
 
Fig. 7. GC × GC contour plot of analysis of the intracellular metabolites extracted from 
spray-quenched human cultured skin fibroblasts 
 
Fig. 8. The comparison of the intracellular levels of mostly deviating metabolites in trypsin 
treated and quenched cells. Natural logarithms of ratios of means and coefficients of 
variation (CV) are shown 
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Fig. 9. PCA projection of the cases and CA dendrogram (complete-linkage, Euclidian 
distance) for the comparison of two cell harvesting methods (based on the listed 72 
metabolites). T1-T6 trypsinization, Q1-Q6 quenching 
5.2 MCF approach 
EZfaast standard solution (contains 32 amino acids and dipeptides), 20 intracellular extracts 
from quenched fibroblasts, and 20 plasma samples derivatized by MCF were analyzed by a 
GC × GC-TOF-MS method and subjected to data processing procedure similarly as 
described in previous sections and the MCF Reference has been made. 
Our MCF Reference currently contains 185 analytes – they are mostly organic acids and 
their derivates (the same as in the TMS approach) and compounds containing amino group 
(the exception is arginine because of the thermal instability of its MCF derivative that carries 
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a free guanidine group). Sugars are another group of compounds that cannot be detected by 
this approach. But that can be an advantage while e.g. cell extracts usually contains an 
excess of sugars that can make the obtained chromatograms not easily interpretable and 
some important markers can be masked. Table 2 shows some MCF-Reference based data 
(2D retention characteristics, unique masses – the characteristic mass identified by the 
ChromaTOF software, and three main ions from the MS spectra).  
Amino acid 
1D; 2D 
RT [s] 
RI 
Unique 
mass 
Derivate 
Mr 
Base 
peak 
P2/% P3/% 
Alanine 476; 2.44 1142 102 161 102 42/65 59/63 
Glycine 484; 2.50 1152 71 147 88 44/62 56/55 
Sarkosine 504; 2.39 1179 102 161 102 42/78 59/49 
Valine 556; 2.38 1255 130 189 130 42/88 59/82 
2-Aminobutyric 
acid 
564; 2.40 1268 88 175 88 44/51 56/41 
Leucine 600, 2.38 1327 88 203 88 59/46 43/43 
Threonine 612; 2.58 1348 115 191 115 59/56 42/37 
Proline 632; 2.64 1383 128 187 41 128/82 41/37 
Asparagine 636; 2.64 1390 127 204 42 127/75 56/72 
Aspargic acid 668; 2.56 1450 160 219 42 59/88 160/69 
Glutamic acid 732; 2.54 1578 114 233 114 59/76 42/70 
Methionine 740; 2.64 1596 61 221 61 59/48 115/40 
4-Hydroxyproline 744; 2.71 1604 144 203 144 41/56 59/47 
2-Aminoadipic acid 784; 2.51 1693 114 247 114 55/70 59/69 
Cysteine 784; 2.69 1694 59 193 59 42/77 44/59 
Phenylalanine 796; 2.68 1720 42 237 42 91/65 59/57 
Glutamine 840; 3.00 1872 84 218 84 44/42 59/41 
Ornithine 884; 2.71 1937 128 262 128 42/51 59/51 
Lysine 920; 2.76 2033 142 218 142 59/82 44/55 
Histidine 940; 3.00 2088 59 227 59 81/76 42/73 
Tyrosine 980; 3.00 2203 121 252 121 59/90 42/73 
Tryptophan 1052; 3.78 2424 130 276 130 77/18 51/11 
Table 2. Table of 22 selected amino acids derivatized via MCF presented in our Reference. 
1D and 2D RT – retention time in first and second dimension, RI – retention index 
(calculated on the basis of absolute RT), P2 and P3/% - second and third most abundant 
peak/percentage of its intensity to the base peak 
5.2.1 Analysis of cultured human skin fibroblasts – effect of cultivation with 5-FU 
Since its synthesis, 5-FU has become one of the most widely used anticancer drugs for a 
variety of common malignancies, including cancers of the colon, breast, skin, and head and 
neck. 5-FU has been used as a component of both first-line chemotherapy regimens and in 
salvage regimens. Despite extensive clinical experience with 5-FU and its effective antitumor 
activity, many concerns remain about the optimal use of this agent. 
5-FU is a prodrug, which is subject to both anabolism and catabolism. The cytotoxic activity 
of 5-FU depends on its anabolism to nucleotides, which exert their effects through inhibition 
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of thymidylate synthase activity or incorporation into RNA and/or DNA. The catabolism of 
5-FU has been better understood only in recent years. The products of 5-FU catabolism have 
been linked to several 5-FU toxicities, including neurotoxicity (Grem, 2000; Kuhn, 2001). 
This study was to show the differences in the fibroblasts metabolome after cultivation with 
addition of 5-FU against the non-treated controls (n=3 for each 6, 24, and 48h treatment, and 
without treatment, respectively), all from a single cell line. Data processing with peak  
 
 
Fig. 10. PCA projection of the cases (up) and the loading plot (down) for the comparison of 
the effect of 5-FU on the fibroblast cultivation. Triplicates (a, b, c) for 6, 24 or 48 hours of 
cultivation with presence of 5-FU and controls (C) are shown 
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finding above S/N 200 was applied to the data, which resulted in the detection of 393-451 
peaks in the set of studied fibroblasts. Our MCF Reference contains 78 identified and 
confirmed intracellular chemical species (from all 185 in the MCF Reference). Data from 
analyses were corrected to percentages of a sum, normalized to the unit standard deviation, 
and statistically analyzed through PCA (Figure 10). Figure 11 shows the differences for the 
most deviating metabolites. From the presented graphs it is clearly visible that cultivation 
with 5-FU influenced fibroblasts’ metabolism. 
 
Fig. 11. Graph of the most increasing (up) and decreasing (down) intracellular metabolites 
influenced by 5-FU. Differences are quantified as percentages of influenced response to the 
non-influenced ones. 
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5.2.2 Analysis of human plasma in relation to metabolic disorders 
In this work we focused on the diagnosis of Inherited Metabolic Disorders in plasma 
samples using a targeted metabolomic approach by GC × GC-TOF-MS. 
 
 
Fig. 12. PCA projection of the cases (up) and a heat map (down) visualized for selected 
amino acids from the analysis of human plasma 
www.intechopen.com
Comprehensive Two-Dimensional Gas Chromatography  
Coupled to Time-of-Flight Mass Spectrometry in Human Metabolomics 
 
47 
Automated data processing with peak finding above S/N 50 was applied to the data, which 
resulted in the detection of 408-594 peaks in the set of studied plasma samples. Our MCF 
Reference contains 65 identified and confirmed plasma chemical species (from all 185 in the 
MCF Reference). 
Prior to statistical analysis the centred logratio (clr) transformation was applied. Data were 
evaluated using PCA and CA based on hierarchical clustering with a complete-linkage 
Euclidian distance method (visualized as a heat map) – Figure 12. 
All the patients’ samples were discriminated from the controls by appropriate metabolites in 
the PCA analysis. Patients with identical disease were recognized using the PCA approach 
and also clustered together. 
6. Conclusion 
This technique has been shown to be very powerful for the purpose of comprehensive 
sample profiling. On selected samples we demonstrated that higher separation power of 
GC × GC can help in removing co-elutions occurring in one dimensional approach. 
GC × GC is a valuable tool in metabolomic analysis of many biological matrices and enables 
diagnosing metabolic disorders. The great benefit is data processing that can be fully 
automated, what strongly simplify operator’s effort and increases the sample throughput. 
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